TSX: HSM     OTC: HSDT

Call us: +1 215-809-2018

people2

The Portable Neuromodulation Stimulator (PoNS™) device is currently an investigational medical device and is not commercially available in the United States (US) or Canada. Helius Medical Technologies (HMT) is investigating the device in the US and Canada for mild to moderate traumatic brain injury (mTBI). HMT intends to use the results of the mTBI study to support an application to FDA for commercial distribution in the U.S. HMT is planning to develop the PoNS™ for additional indications for use.